By binding to IgG, FCGR3A participates in the induction and regulation of inflammatory processes, leading to the release of proinflammatory cytokines and other tissue-destructive mediators from activated monocytes/macrophages, which may contribute to the development of psoriasis [55]. This evidence concerns the gene FCGR3A and psoriasis.